Institute Of Medical Biology, Chinese Academy Of Medical Sciences
Clinical trials sponsored by Institute Of Medical Biology, Chinese Academy Of Medical Sciences, explained in plain language.
-
New Low-Dose tdap vaccine trial aims to protect older kids and adults
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new version of the tetanus, diphtheria, and pertussis (whooping cough) vaccine that uses fewer antigens to reduce side effects. It involves 660 volunteers aged 6 years and older to check if the vaccine is safe and triggers a strong immune response. The trial is…
Phase: PHASE1, PHASE2 • Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 08:46 UTC
-
New vaccine aims to shield against hand, foot, and mouth disease
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage trial tests a new vaccine designed to protect against hand, foot, and mouth disease (HFMD) caused by two common viruses. About 144 healthy people aged 6 months to 59 years will receive either the vaccine or a placebo. The main goal is to check the vaccine's safet…
Phase: PHASE1 • Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences • Aim: ⭐️ VACCINE ⭐️
Last updated May 06, 2026 16:03 UTC